tiprankstipranks
Anatara Lifesciences Ltd (AU:ANR)
ASX:ANR
Australian Market
Holding AU:ANR?
Track your performance easily

Anatara Lifesciences Ltd (ANR) Income Statement

0 Followers

Anatara Lifesciences Ltd Income Statement

Last quarter (Q4 2022), Anatara Lifesciences Ltd's total revenue was AU$―, a decrease of ― from previous quarter. In Q4, Anatara Lifesciences Ltd's net income was AU$―. See Anatara Lifesciences Ltd’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jun 22Jun 21Jun 20Jun 19
Total Revenue
----AU$ 663.40K
Cost of Revenue
-----
Gross Profit
----AU$ 663.40K
Operating Expense
-AU$ 3.02MAU$ 3.11MAU$ 4.21MAU$ 4.48M
Operating Income
-AU$ -3.02MAU$ -3.11MAU$ -4.21MAU$ -3.82M
Net Non Operating Interest Income Expense
-AU$ 2.69KAU$ 8.82KAU$ 52.06KAU$ 142.50K
Other Income Expense
-AU$ 487.24KAU$ 1.11MAU$ 789.21KAU$ 807.97K
Pretax Income
-AU$ -2.53MAU$ -2.00MAU$ -3.36MAU$ -2.87M
Tax Provision
-AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Earnings From Equity Interest Net Of Tax
-----
Net Income Common Stockholders
-AU$ -2.53MAU$ -2.00MAU$ -3.36MAU$ -2.87M
Basic EPS
-AU$ -0.03AU$ -0.03AU$ -0.07AU$ -0.06
Diluted EPS
-AU$ -0.03AU$ -0.03AU$ -0.07AU$ -0.06
Basic Average Shares
-AU$ 73.43MAU$ 62.71MAU$ 49.67MAU$ 49.41M
Diluted Average Shares
-AU$ 73.43MAU$ 62.71MAU$ 49.67MAU$ 49.41M
Dividend Per Share
-----
Total Operating Income As Reported
-----
Reported Normalized Basic E P S
-----
Reported Normalized Diluted E P S
-----
Rent Expense Supplemental
-----
Total Expenses
-----
Net Income From Continuing And Discontinued Operation
-AU$ -2.53MAU$ -2.00MAU$ -3.36MAU$ -2.87M
Normalized Income
-AU$ -2.53MAU$ -2.00MAU$ -3.36MAU$ -2.87M
Interest Expense
-AU$ 3.32KAU$ 300.00--
EBIT
-AU$ -2.53MAU$ -2.00MAU$ -4.21MAU$ -3.82M
EBITDA
-AU$ -2.50MAU$ -1.99MAU$ -4.19MAU$ -3.80M
Currency in AUD

Anatara Lifesciences Ltd Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis